BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24511009)

  • 21. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.
    Su D; Ma S; Liu P; Jiang Z; Lv W; Zhang Y; Deng Q; Smith S; Yu H
    Lung Cancer; 2007 May; 56(2):281-8. PubMed ID: 17222938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship of metalloproteinase gene polymorphisms and lung cancer.
    Sanli M; Akar E; Pehlivan S; Bakır K; Tuncozgur B; Isik AF; Pehlivan M; Elbeyli L
    J Surg Res; 2013 Aug; 183(2):517-23. PubMed ID: 23465389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
    Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
    Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
    Farjadfar A; Mojtahedi Z; Ghayumi MA; Erfani N; Haghshenas MR; Ghaderi A
    Acta Oncol; 2009; 48(7):971-6. PubMed ID: 19642044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
    Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
    Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intronic polymorphism (1541-1542delGT) of the constitutive heat shock protein 70 gene has functional significance and shows evidence of association with lung cancer risk.
    Rusin M; Zientek H; Krześniak M; Małusecka E; Zborek A; Krzyzowska-Gruca S; Butkiewicz D; Vaitiekunaite R; Lisowska K; Grzybowska E; Krawczyk Z
    Mol Carcinog; 2004 Mar; 39(3):155-63. PubMed ID: 14991745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.
    Pang Q; Wei Q; Xu T; Yuan X; Lopez Guerra JL; Levy LB; Liu Z; Gomez DR; Zhuang Y; Wang LE; Mohan R; Komaki R; Liao Z
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1332-9. PubMed ID: 23374503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer.
    Cui E; Deng A; Wang X; Wang B; Mao W; Feng X; Hua F
    Biochem Cell Biol; 2011 Jun; 89(3):308-13. PubMed ID: 21619462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
    Landvik NE; Hart K; Skaug V; Stangeland LB; Haugen A; Zienolddiny S
    Carcinogenesis; 2009 Jul; 30(7):1186-92. PubMed ID: 19461122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin.
    Tiseo M; Giovannetti E; Tibaldi C; Camerini A; Di Costanzo F; Barbieri F; Burgers JA; Vincent A; Peters GJ; Smit EF; Ardizzoni A
    Lung Cancer; 2012 Oct; 78(1):92-9. PubMed ID: 22889494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 polymorphism in non-small cell lung cancer in a Portuguese population.
    Catarino R; Coelho A; Nogueira A; Araújo A; Gomes M; Lopes C; Medeiros R
    Cancer Biomark; 2012; 12(2):65-72. PubMed ID: 23396251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients.
    Sun X; Li F; Sun N; Shukui Q; Baoan C; Jifeng F; Lu C; Zuhong L; Hongyan C; YuanDong C; Jiazhong J; Yingfeng Z
    Lung Cancer; 2009 Aug; 65(2):230-6. PubMed ID: 19157633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A polymorphism in the 5'-flanking region of the CYP2E1 gene and elevated lung adenocarcinoma risk in a Japanese population.
    Iizasa T; Baba M; Saitoh Y; Suzuki M; Haga Y; Iyoda A; Chang H; Hiroshima K; Itoga S; Tomonaga T; Nomura F; Fujisawa T
    Oncol Rep; 2005 Oct; 14(4):919-23. PubMed ID: 16142352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HSP90 family of genes in the human genome: insights into their divergence and evolution.
    Chen B; Piel WH; Gui L; Bruford E; Monteiro A
    Genomics; 2005 Dec; 86(6):627-37. PubMed ID: 16269234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.